Tailored drug cocktail may improve kidney transplant success
NCT ID NCT07633600
First seen Jun 11, 2026 · Last updated Jun 23, 2026 · Updated 2 times
Summary
This study tests whether giving specific blood pressure drugs based on real-time heart and vessel measurements can improve fluid management during kidney transplant surgery. Researchers will assign 255 adults to receive vasopressin, norepinephrine, calcium chloride, or dopamine depending on their circulation type. The goal is to see if this personalized approach leads to better responses to intravenous fluids.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars Sinai Medical Center
Los Angeles, California, 90048, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Vasopressin, Norepinephrine, Calcium Chloride, Dopamine
What this could lead to
If it works, this could lead to better fluid management during kidney transplants, potentially improving outcomes and reducing complications.
What could go wrong
This is a Phase 4 trial that has not yet started recruiting. The approach is highly specific to the operating room and may not translate to broader benefits. Risks include side effects from the vasoactive drugs.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.